New Tools for Imaging Retinal Inflammation
-
By
-
Jim Gallagher, senior managing editor
-
May 1, 2026
-
4 min
By
Jim Gallagher, senior managing editor
May 1, 2026
Uveitis Corner: Survey data and specialist insights challenge long-standing misconceptions about uveitis training, surgery, and compensation.
Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven
by Kerri Miller
May 7, 2026